M B Parr
Overview
Explore the profile of M B Parr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parr E, Holliday E, Collard M, Parr M
Arch Virol
. 2005 Apr;
150(9):1885-902.
PMID: 15824886
An adult mouse model for studies of latency and recurrence after vaginal HSV-2 infection is not available at present, largely because the infection kills most mice within 14 days. We...
2.
Parr M, Parr E
Immunology
. 2000 Sep;
101(1):126-31.
PMID: 11012763
We investigated the involvement of antibody in protection against vaginal herpes simplex virus type-2 (HSV-2) infection by comparing intact and B-cell knockout (KO) mice. Vaginal immunization of intact mice with...
3.
Parr M, Parr E
Immunology
. 2000 May;
99(4):540-5.
PMID: 10792501
Lymphocyte recruitment into tissues involves interactions between adhesion molecules on vascular endothelial cells and corresponding ligands on the lymphocyte surface. In the present study we investigated the expression of four...
4.
Parr E, Parr M
Immunology
. 1999 Dec;
98(4):639-45.
PMID: 10594699
We compared nasal and vaginal immunizations using attenuated herpes simplex virus type-2 (HSV-2) for protection against vaginal infection with wild-type HSV-2. Mice were immunized once intranasally, intravaginally after progestin (DP)...
5.
Parr M, Parr E
Virology
. 1999 Jun;
258(2):282-94.
PMID: 10366565
We investigated the role of interferon gamma (IFN-gamma) in a mouse model of immunity to vaginal infection by herpes simplex virus type 2 (HSV-2). Within 8 h after immune mice...
6.
Parr M, Harriman G, Parr E
Immunology
. 1998 Nov;
95(2):208-13.
PMID: 9824477
An immunoglobulin A (IgA) knockout (KO) mouse was used to study the role of IgA in protective immunity against vaginal infection with herpes simplex virus-type 2 (HSV-2). Intact and KO...
7.
Parr E, Bozzola J, Parr M
J Reprod Immunol
. 1998 Jun;
38(1):15-30.
PMID: 9616875
Progestin-treated female mice are susceptible to vaginal infection by two sexually transmitted disease organisms: herpes simplex virus type 2 (HSV-2) and Chlamydia trachomatis. Vaccination of mice with HSV-2 or chlamydial...
8.
Parr E, Parr M
J Virol
. 1998 May;
72(6):5137-45.
PMID: 9573285
This investigation evaluated immunity to vaginal herpes simplex virus type 2 (HSV-2) infection after local or parenteral immunization with attenuated HSV-2. Vaginal immunization induced sterilizing immunity against challenge with a...
9.
King N, Parr E, Parr M
J Immunol
. 1998 May;
160(3):1173-80.
PMID: 9570531
To determine whether lymphocytes and Langerhans cells in vaginal epithelium are migratory, we stained mouse vaginal epithelium, including its lymphoid cells, by intraluminal administration of H33342, a fluorescent, vital dye....
10.
Parr M, Parr E
J Virol
. 1998 Apr;
72(4):2677-85.
PMID: 9525585
Intravaginal (IVAG) inoculation of wild-type herpes simplex virus type 2 (HSV-2) in mice causes epithelial infection followed by lethal neurological illness, while IVAG inoculation of attenuated HSV-2 causes epithelial infection...